ロード中...
Protein Kinase Cα Mediates Erlotinib Resistance in Lung Cancer Cells
Overexpression and mutational activation of the epidermal growth factor receptor (EGFR) plays an important role in the pathogenesis of non–small cell lung cancer (NSCLC). EGFR tyrosine-kinase inhibitors (TKIs) are given as a primary therapy for advanced patients with EGFR-activating mutations; howev...
保存先:
| 出版年: | Mol Pharmacol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4407729/ https://ncbi.nlm.nih.gov/pubmed/25724832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.097725 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|